PBMs do not have to be this way.
Every claim itemized to the cent and auditable the moment it happens. Prior auth in seconds, not days. And the drug passed straight through at cost. No spread, the rebate yours. Here is a claim, with nothing hidden.
For self-funded & level-funded employers, and the advisors who serve them.
Kanurra
Pass-through pharmacy
Prescription
Semaglutide 0.5mg
1 pen · 28-day · GLP-1
They hand you one number.
Peel it back.
Your PBM bills a single line with no detail. Tap the bill to expose the money they did not itemize.
What they bill you
no detail.
What was actually inside
The $484.00 they pocketed, back in your plan.
Your old PBM made money twice on this claim. The spread, and your rebate.
We make nothing on the claim. The drug passes straight through at cost, rebate and all. We charge one flat per-member-per-month fee, disclosed in your contract, and nothing else. Nothing to find later, because there is nothing hidden now.
- $0.00spread or markup, on every claim, forever
- 100%of every rebate we capture, credited to you. We keep none
- 1 feeflat, per member per month, disclosed up front
The spread and retained rebate shown are what an incumbent keeps under a typical spread contract; the split varies by deal. Rebate dollars vary by drug and by the manufacturer agreements in force, and will differ from an incumbent's book. What never varies: we keep none of them.
Auditable is a verb.
Click any line. Go ahead.
Every claim, itemized to the cent. Open any row for its full audit detail. No quarterly PDF. No redaction.
Audit detail · CLM-1306
hash 25c6…d94
- Acquisition cost (NADAC)
- $0.85
- Pharmacy dispensing fee
- $1.50
- Kanurra markup
- $0.00
- Spread charged
- $0.00
- Rebate retained by Kanurra
- $0.00
- Legacy PBM would bill
- $4.50
Audit detail · CLM-1307
hash 26c6…dad
- Acquisition cost (NADAC)
- $0.79
- Pharmacy dispensing fee
- $1.50
- Kanurra markup
- $0.00
- Spread charged
- $0.00
- Rebate retained by Kanurra
- $0.00
- Legacy PBM would bill
- $4.50
Audit detail · CLM-1308
hash 17c6…c34
- Acquisition cost (NADAC)
- $3.80
- Pharmacy dispensing fee
- $1.50
- Kanurra markup
- $0.00
- Spread charged
- $0.00
- Rebate retained by Kanurra
- $0.00
- Legacy PBM would bill
- $11.00
Audit detail · CLM-1309
hash 18c6…c4d
- Acquisition cost (NADAC)
- $4.75
- Pharmacy dispensing fee
- $1.50
- Kanurra markup
- $0.00
- Spread charged
- $0.00
- Rebate retained by Kanurra
- $0.00
- Legacy PBM would bill
- $12.00
Audit detail · CLM-1310
hash a5c9…e16
- Acquisition cost (NADAC)
- $1.16
- Pharmacy dispensing fee
- $1.50
- Kanurra markup
- $0.00
- Spread charged
- $0.00
- Rebate retained by Kanurra
- $0.00
- Legacy PBM would bill
- $5.50
Audit detail · CLM-1311
hash a4c9…dfc
- Acquisition cost (NADAC)
- $0.50
- Pharmacy dispensing fee
- $1.50
- Kanurra markup
- $0.00
- Spread charged
- $0.00
- Rebate retained by Kanurra
- $0.00
- Legacy PBM would bill
- $4.00
Audit detail · CLM-1312
hash a3c9…de3
- Acquisition cost (NADAC)
- $1.69
- Pharmacy dispensing fee
- $1.50
- Kanurra markup
- $0.00
- Spread charged
- $0.00
- Rebate retained by Kanurra
- $0.00
- Legacy PBM would bill
- $6.50
The same detail your auditor sees. Access is role-based: the money is auditable without exposing a member's identity.
Do not take our word.
Drive it yourself.
Pick a drug. Pick a group size. Watch the savings compute. Then run it on your own claims.
Illustrative. Generic savings come from eliminating spread; specialty and GLP-1 savings come from passing 100% of the manufacturer rebate back to the plan, and from biosimilar substitution. Figures use representative NADAC/WAC costs and each drug's typical share of a commercial plan's fills, gross of our flat per-member-per-month admin fee. Your real claims will differ.
Annual drug savings · Semaglutide (GLP-1) · 250 lives
$0
Per fill saved
$484.00
Fills / month
10
Saved / month
$4,840
Days at a legacy PBM.
Seconds here.
AI-run prior auth, evidence-based, with a clinician on the cases that need one. An illustrative walkthrough of the clean path, start to finish.
Time to decision · target
- 1Submitted
- 2AI review
- 3Evidence
- 4Clinician
- 5Approved
Request submitted
Semaglutide 1mg · member #4471
The incumbents made you wait because waiting was cheaper for them.
The AI never denies. It approves the clean cases and routes everything else to a licensed clinician. A faster yes is never an automated no. A pharmacist owns the criteria and signs anything off-pathway, with the exact criteria logged on every decision.
14s
Kanurra target
2–5 days
Legacy PBM
Switching is the part you fear.
So we made it boring.
We rent the proven rails the industry already runs on. The plumbing works; we just refuse to hide what flows through it.
01
Disruption analysis first
Before anything moves, we model every member's current fills against the new plan. Nothing is a surprise on day one.
02
Same pharmacies
No network change. Every member keeps the counter they already use, with the same card in their wallet.
03
We do the paperwork
Eligibility files, ID cards, and member comms, with continuity on open prior auths, specialty, and GLP-1. Your team approves each step.
04
A human at go-live
Named, on the phone, the day the switch goes live. Not a ticket queue.
Recommend it without betting your name on a black box.
- Every claim auditable. You put your name on a number your client can open and check.
- Defensible under CAA fee disclosure: clients see exactly what they pay, and why. You arrive ahead of the rules, not behind them.
- You keep your client and your contract. Compensation disclosed and flat, paid from our margin, and we never go direct to your book.
- You look smarter for finding it: a pharmacy line your client can defend to their board.
A benefit you can defend to your board.
- Pay the pharmacy's real cost, not a hidden markup, without changing networks.
- Every fill auditable in real time. No quarterly mystery.
- Minimal member disruption: same pharmacies, a modeled transition, a named human on the phone at go-live.
Questions a
fiduciary asks.
What does 'pass-through' actually mean?+
You pay exactly what the pharmacy was paid for the drug: no markup, no spread, 100% of rebates credited back. Our only charge is a separate flat per-member-per-month administrative fee, disclosed in your contract. The drug cost is printed on every claim and reconciled to the cent.
What happens to manufacturer rebates?+
100% of every rebate we capture is credited directly to your plan, line-itemed in the ledger as it arrives. We keep none as revenue. Rebate dollars depend on the manufacturer agreements in force and will differ from an incumbent's book. What does not differ is that we retain zero, and our contracts are visible to the plan sponsor.
Why should I trust a brand-new PBM?+
You shouldn't. You should check us. Every claim is auditable in real time, down to the dollar: acquisition cost, dispensing fee, $0 spread, rebate credited back. We are not asking for the benefit of the doubt; we are removing the need for it. And the parts that have to be battle-tested are not new. We run on established claim-adjudication, pharmacy-network, and rebate rails the industry already relies on. What is new is the only thing that should be: a PBM that shows its work. Ask, and we name them: the adjudication platform, pharmacy network, and rebate aggregator are disclosed in diligence and fixed in your contract.
Will moving to Kanurra disrupt my members?+
No network change is required. Members keep their pharmacies. We did not rebuild the plumbing; we run on the same proven adjudication engine, network, and rebate infrastructure the incumbents use, with a transparent, flat-fee, auditable layer on top. Before anything moves we run a disruption analysis. Then we handle the eligibility files, ID cards, and member comms, with your team approving each step, and continuity on open prior authorizations, specialty, and GLP-1 therapies. Members see the same counter, a clearer copay, and faster prior auth.
How fast can a group go live?+
Most groups implement in about four to eight weeks. Because we rent the proven rails rather than reinventing them, go-live is not a science project. It is eligibility, formulary, and pharmacy-network setup on infrastructure that already works, with a named human on the phone at go-live and your team reviewing and approving every step.
How does the advisor or TPA get paid?+
Your compensation is disclosed and flat, paid out of our margin, never carved from spread or a rebate the employer cannot see. You keep your client relationship and your master contract, and we do not go direct to a partner's book. The same fee disclosure that protects the employer protects you: it puts you ahead of the CAA and DOL transparency rules instead of exposed by them.
Who is clinically accountable?+
A licensed pharmacist owns the formulary and signs every off-pathway prior-authorization decision, with the exact criteria applied logged on each claim. The AI never denies. It approves the clean cases and escalates everything else to a clinician. Your clinical contacts are named in your contract.
How does Kanurra make money?+
Only the flat per-member-per-month administrative fee. Not spread, not rebate retention, not formulary placement, not pharmacy steering. That is the entire point.
See the real cost.
Then never go back.
Run a no-cost claims audit against your current PBM. Most plans find hidden money in the first audit.